| Call Topic |
Acronym |
Instrument |
Title |
Website |
| 2002-2.1.1-4 |
Eumitocombat |
IP |
Rational treatment strategies combating mitochondrial oxidative phosphorylation (OXPHOS) disorders |
WWW |
| 2002-2.1.1-7 |
EUGINDAT |
STREP |
European genomics initiative on disorders of plasma membrane amino acid transporters |
WWW |
| 2002-2.1.1-9 |
EuroWilson |
CA |
Wilson disease: creating a European clinical database and designing multicentre randomised controlled clinical trials |
WWW |
| 2002-2.1.1-12 |
Orphanplatform |
SSA |
Platform of information services for the coordination of rare disease research with various stakeholders from research, SMEs and patient organisations and the coordination of early clinical trials |
WWW |
| 2002-2.1.3-4 |
EUROSCA |
IP |
European integrated project on spinocerebellar ataxias (EUROSCA): Pathogenesis, genetics, animal models and therapy |
WWW |
| 2002-2.1.3-7 |
X-ALD |
STREP |
X-linked Adrenoleukodystrophy (X-ALD): pathogenesis, animal models and therapy |
NONE as yet |
| 2002-2.1.3-7 |
NEUROKCN
QPATHIES |
STREP |
Cell biology of rare monogenic neurological disorders involving KCNQ channels |
WWW |
| 2002-2.1.3-7 |
NCL-MODELS |
STREP |
Dissecting neuronal degeneration: Neuronal ceroid lipofuscinoses from genes to function |
WWW |
| 2002-2.1.3-7 |
SPASTIC
MODELS |
STREP |
Genetic Models of Chronic Neuronal Degeneration Causing Hereditary Spastic Paraplegia |
WWW |
| 2002-2.2.0-8 |
PROTHETS |
STREP |
Prognosis and Therapeutic Targets in the Ewing Family of Tumours |
WWW |
| 2003-2.1.1-5 |
EURAPS |
STREP |
Autoimmune polyendocrine syndrome type I - a rare disorder of childhood as a model for autoimmunity |
WWW |
| 2003-2.1.1-5 |
AUTOROME |
STREP |
From Immune Responses in Rare Autoimmune Diseases to novel Therapeutic Intervention Strategies-a personalized Medicine approach |
WWW |
| 2003-2.1.1-4 |
PWS |
STREP |
Prader-Willi Syndrom: a model linking gene expression, obesity and mental health |
NONE as yet |
| 2003-2.1.1-7 |
GENESKIN |
CA |
Rare genetic skin diseases: advancing diagnosis, management and awareness through a european network |
WWW |
| 2003-2.1.1-8 |
EURO
GLYCANET |
CA |
Congenital Disorders of Glycosylation: a European network for the advancement of research, diagnosis and treatment of a growing group of rare disorders |
WWW |
| 2004-2.1.1-3 |
PULMOTENSION |
IP |
Pulmonary Hypertension: Functional Genomics and Therapy of Lung Vascular Remodelling |
WWW |
| 2004-2.1.1-9 |
PolyALA |
STREP |
Insights into novel therapeutic strategies for a nuclear inclusion disease caused by polyalanine expansion |
WWW |
| 2004-2.1.1-9 |
EURO-Laminopathies |
STREP |
Nuclear Envelope-linked Rare Human Diseases: From Molecular Pathophysiology towards Clinical Applications |
WWW |
| 2004-2.1.1-10 |
HUE-MAN |
STREP |
Towards the Development of an Effective Enzyme Replacement Therapy for Human Alpha-Mannosidosis |
WWW |
| 2004-2.1.1-11 |
EuroCareCF |
CA |
European Coordination Action for Research in Cystic Fibrosis |
WWW |
| 2004-2.2.0-1 |
CONTICANET |
NoE |
Connective Tissue Cancers Network to integrate European experience in adults and children |
WWW |
| 2004-2.2.0-1 |
EuroBoNet |
NoE |
European network to promote research into uncommon cancers in adults and children: Pathology, Biology and Genetics of Bone Tumors |
WWW |
| 2004-2.2.0-6 |
MMR-related cancer |
NoE |
Prevention, diagnosis and molecular characterisation of mismatch repair defect-related hereditary cancers of the digestive system |
WWW |
| 2005-2.1.1-7 |
TREAT-NMD |
NoE |
Translational Research in Europe - Assessment and Treatment of Neuromuscular Diseases |
WWW |
| 2005-2.1.1-8 |
EURAMY |
STREP |
Systemic Amyloidoses in Europe |
WWW |
| 2005-2.1.1-9 |
EuroGrow |
STREP |
Pathophysiology of the cartilage growth plate |
WWW |
| 2005-2.1.1-12 |
MYASTAID |
SME-STREP |
Development of models to improve management of Myasthenia Gravis: From basic knowledge to clinical application |
WWW |
| 2005-2.1.3-7 |
RATstream |
SME-STREP |
European project on the characterisation of transgenic rat models for neurodegenerative and psychiatric diseases: Automated home cage analyses, live imaging and treatment |
WWW |
| 2005-2.1.3-8 |
TAMAHUD |
SME-STREP |
Identification of early disease markers, novel pharmacologically tractable targets and small molecule phenotypic modulators in Huntington's Disease |
NONE as yet |
| Call Topic |
Acronym |
Instrument |
Title |
Website |
| 2002-1.2.2-1 |
SAFE |
NoE |
Special non-invasive advances in foetal and neonatal evaluation network |
WWW |
| 2003-1.2.2-1 |
EUROGENTEST |
NoE |
Genetic testing in Europe - Network for test development harmonization, validation and standardization of services |
WWW |
| 2003-1.2.2-3 |
UBIGENES |
STREP |
Genetics of coenzyme Q deficiency in humans |
WWW |
| 2003-1.2.2-3 |
Mitocircle |
STREP |
Mitochondrial diseases: From bedside to genome to bedside |
WWW |
| 2003-1.2.4-2 |
CONSERT |
IP |
Concerted Safety & Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases |
WWW |
| 2003-1.2.4-7 |
Improved
precision |
STREP |
Improved precision of nucleic acid based therapy of cystic fibrosis |
WWW |
| 2003-1.2.4-8 |
SKINTHERAPY |
STREP |
Gene therapy for Epidermolysis Bullosa: a model system for treatment of inherited skin diseases |
NONE as yet |
| 2003-1.2.4-8 |
THERAPEUSKIN |
STREP |
Ex vivo gene therapy for recessive dystrophic epidermolysis bullosa : pre-clinical and clinical studies |
NONE as yet |
| 2004-1.2.1-3 |
EPISTEM |
IP |
Role of p63 and related pathways in epithelial stem cell proliferation and differentiation and in rare EEC-related syndromes |
WWW |
| 2004-1.2.2-4 |
TSEUR |
STREP |
An integrated immunological and cellular strategy for sensitive TSE diagnosis and strain discrimination |
NONE as yet |
| 2004-1.2.2-4 |
AntePrion |
STREP |
Development of a pre-clinical blood test for prion diseases |
WWW |
| 2004-1.2.4-3 |
CLINIGENE |
NoE |
European Network for the Advancement of Clinical Gene Transfer and Therapy |
WWW |
| 2004-1.2.4-4 |
SyntheGeneDelivery |
STREP |
Ex vivo gene delivery for stem cells of clinical interests using synthetic processes of cellular and nuclear import and targeted chromosomal integration |
NONE as yet |
| 2004-1.2.4-4 |
INTHER |
STREP |
Development and application of transposons and site-specific integration technologies as non-viral gene delivery methods for ex vivo gene-based therapies |
NONE as yet |
| 2004-1.2.4-4 |
magselectofection |
STREP |
Combined isolation and stable nonviral transfection of hematopoietic cells: a novel platform technology for ex vivo hematopoietic stem cell gene therapy |
WWW |
| 2005-1.2.4-1 |
EuroSTEC |
IP |
Soft tissue engineering for congenital birth defects in children: new treatment modalities for spina bifida, urogenital and abdominal wall defects |
WWW |
| 2005-1.2.4-5 |
STEM-HD |
STREP |
Embryonic stem cells for therapy and exploration of mechanisms in Huntington Disease |
WWW |
| 2005-1.2.4-6 |
BACULOGENES |
STREP |
Baculovirus vectors for gene therapy |
WWW |
| 2005-1.2.4-7 |
MYOAMP |
SME-STREP |
Amplification of human myogenic stem cells in clinical conditions |
NONE as yet |
| 2005-1.2.5-3 |
znip |
STREP |
Therapeutic in vivo DNA repair by site-specific double-strand breaks |
NONE as yet |
You are here: Home Page | Thematic Areas | Combating Major Diseases | Combating cardiovascular disease, diabetes and rare diseases | FP6 rare diseases projects (at mid-term of FP6) 
